The Effect of an Apparent Change to a Branded or Generic Medication on Drug Effectiveness and Side Effects
The DOI matches its Crossref record; 10 of the 10 references it cites were found in a registry or an index.
Abstract
OBJECTIVE: Generic medications are associated with reduced perceived effectiveness, increased perceived adverse effects, and increased rates of nonadherence compared with brand-name medications. This study examined the effect of an apparent medication formulation change on subjective and objective measures of medication effectiveness and medication side effects. METHODS: Sixty-two university students participated in a study purportedly testing the effectiveness of fast-acting β-blocker medications in reducing preexamination anxiety. All tablets were placebos. In session 1, all participants received a yellow tablet ("Betaprol"). In session 2, participants were randomly allocated to receive Betaprol (no change condition) or a white tablet labeled either as "Novaprol" (branded change condition) or "Generic" (generic change condition). Blood pressure and state anxiety were measured before and after tablet ingestion. Side effects attributed to medication were assessed. RESULTS: The no change group showed significantly greater decreases in systolic blood pressure (mean [M] [standard deviation] = -7.72 mm Hg, standard error [SE] = 1.45) than the branded change (M = -2.75 mm Hg, SE = 1.44, p = .02) and generic change (M = -3.26 mm Hg, SE = 1.45, p = .03) groups. The no-change group showed significantly greater decreases in state anxiety (M = -1.53, SE = 0.33) than the branded change (M = -0.50, SE = 0.33, p = .03) and generic change (M = -0.52, SE = 0.33, p = .04) groups. Significantly more side effects were attributed to the medication in the generic change (M = 1.83, SE = 0.23) (but not the branded change) condition when compared with the no change condition (M = 0.87, SE = 0.31, p = .03). CONCLUSIONS: Medication formulation change, particularly to generic medication, seems to be associated with reduced subjective and objective measures of medication effectiveness and increased side effects.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
No adjustments are needed for multiple comparisons.
Rothman, K. J. (1990) · Epidemiology · doi:10.1097/00001648-199001000-00010 · Cited by 5,965
Marteau, T. M., & Bekker, H. (1992) · British Journal of Clinical Psychology · doi:10.1111/j.2044-8260.1992.tb00997.x · Cited by 3,238 · cited 2×
“Anxiety Measures State anxiety was measured using the six-item short-form of the state scale of the Spielberger State-Trait Anxiety Inventory (36), which yields a minimum score of 6 (not anxious at all) and a maximum score of 24 (extremely anxious).”
MethodAnalysing controlled trials with baseline and follow up measurements
Vickers, A. J., & Altman, D. G. (2001) · BMJ · doi:10.1136/bmj.323.7321.1123 · Cited by 2,116
Do multiple outcome measures require p-value adjustment?
Feise, R. J. (2002) · BMC Medical Research Methodology · doi:10.1186/1471-2288-2-8 · Cited by 1,299
Placebos without Deception: A Randomized Controlled Trial in Irritable Bowel Syndrome
Kaptchuk, T. J., Friedlander, E., Kelley, J. M., Sanchez, M. N., Kokkotou, E., Singer, J. P., Kowalczykowski, M., Miller, F. G., Kirsch, I., & Lembo, A. J. (2010) · PLoS ONE · doi:10.1371/journal.pone.0015591 · Cited by 900 · cited 1×
“The power of expectations is such that benefit may be derived from open placebo treatment, which is presented as being effective at treating the patients’ condition (11).”
BackgroundNonspecific medication side effects and the nocebo phenomenon
Barsky, A. J. (2002) · JAMA · doi:10.1001/jama.287.5.622 · Cited by 784
A scoring system for subjective health complaints (SHC)
Eriksen, H. R., Ihlebæk, C., & Ursin, H. (1999) · Scandinavian Journal of Public Health · doi:10.1177/14034948990270010401 · Cited by 415
Nocebo effects, patient–clinician communication, and therapeutic outcomes
Colloca, L., & Finniss, D. (2012) · JAMA · doi:10.1001/jama.2012.115 · Cited by 326
Role of expectations in health
Colloca, L., & Miller, F. G. (2011) · Current Opinion in Psychiatry · doi:10.1097/yco.0b013e328343803b · Cited by 161 · cited 1×
“Expectations can be generated from the provision of information, social interactions, beliefs about treatment, and personal experience (6,7), including negative information provided during the informed consent process and personal experience with unsuccessful treatments in the case of nocebo effects (8,9).”
BackgroundThyroxine: anatomy of a health scare
Faasse, K., Cundy, T., & Petrie, K. J. (2009) · BMJ · doi:10.1136/bmj.b5613 · Cited by 72
Self-citation
Cited by
Schedlowski, M., Enck, P., Rief, W., & Bingel, U. (2015) · Pharmacological Reviews · doi:10.1124/pr.114.009423 · Cited by 323
“counterbalanced experimental approaches (Faasse et al., 2013).”
BackgroundInfluentialPetrie, K. J., & Rief, W. (2019) · Annual Review of Psychology · doi:10.1146/annurev-psych-010418-102907 · Cited by 309
“In students, positive expectations can help to reduce heart rate and blood pressure reactions in test anxiety situations (Faasse et al. 2013).”
BackgroundSelf-citationA systematic review of factors that contribute to nocebo effects
Webster, R. K., Weinman, J., & Rubin, G. J. (2016) · Health Psychology · doi:10.1037/hea0000416 · Cited by 172
“This could also explain the significance of medication brand, with branded medication being generally expected by the public to be better quality than generic unbranded medication and therefore less likely to cause side effects (Faasse et al., 2013).”
BackgroundMethodResultInfluentialPlacebo 2.0: the impact of expectations on analgesic treatment outcome
Bingel, U. (2020) · Pain · doi:10.1097/j.pain.0000000000001981 · Cited by 113
Placebo and nocebo effects across symptoms: from pain to fatigue, dyspnea, nausea, and itch
Wolters, F., Peerdeman, K. J., & Evers, A. W. M. (2019) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2019.00470 · Cited by 57
“Comparisons might also be valuable for predictors with clear implications for clinical practice, such as the perceived cost of the placebo (128, 129), the odds of receiving placebo (51, 130), the invasiveness of the placebo (131, 132), other interventions that could enhance the effect of placebos (133), or pre-existin…”
Background
Metadata
- Authors
- Faasse, K., Cundy, T., Gamble, G., & Petrie, K. J.
- Venue
- Psychosomatic Medicine
- Published
- 2013-01
- Volume
- 75
- Issue
- 1
- Pages
- 90-96
- ISSN
- 0033-3174 (ISSN-L)
- OpenAlex
- W2090886282
- Cited by
- 96
- References
- 10
- FWCI
- 12.12
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.